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Paleo-soraphens: chemical total syntheses and
biological studies†
Hai-Hua Lu,a Bettina Hinkelmann,b Thomas Tautz,a Jun Li,a Florenz Sasse,b
Raimo Frankeb and Markus Kalesse*a,b
The soraphens are natural products that exhibit a molecular structure diﬀerent from what would have
been expected by following its polyketidal assembly line. The most signiﬁcant diﬀerences are the pres-
ence of a hemiketal instead of a trisubstituted double bond and a double bond at C9 and C10 where a
saturated carbon chain was expected. We were interested in the biological activity of the soraphens with
architectures as described by the polyketide synthase since we hypothesized that these modiﬁcations
reﬂect the evolutionary optimization of the soraphens. Herein we describe four additional derivatives of
the so-called paleo-soraphens and their biological proﬁling to provide a picture of the hypothetical evol-
utionary optimization of this family of natural products. The syntheses required a uniﬁed and convergent
strategy and their biological proﬁling was performed with the aid of impedance measurements. The
results of these biological experiments are consistent with the proposed evolutionary optimization of the
soraphens.
Introduction
Natural products are the source of biologically active com-
pounds and in particular secondary metabolites isolated from
microorganisms have been in the focus of natural product
chemistry for quite some time. One of the most fundamental
questions associated with natural products is the question on
the origin of their biological activity and the ultimate purpose
of their existence. While questions on the genuine relevance of
natural products are answered by working groups concerned
with the ecological aspects of natural products, the question of
how the activity was generated in the first place is still
unknown. With this state of knowledge, we started a program
that aimed at providing natural products as if they were
derived by the precise specification of polyketide synthases.1
Based on this concept and previous contributions on the bio-
synthesis of soraphens2 we recently described the synthesis
and biological evaluation of two so-called paleo-soraphens of
which one exhibited a biological activity completely diﬀerent
from the natural soraphen A (7).3 This result supported the
hypothesis that biological activities can be altered by turning
oﬀ distinct enzymatic activities within polyketide synthases.
In order to shed more light on this topic we completed the
syntheses of four additional paleo-soraphens, which exhibit
modifications associated with the hypothetical evolutionary
optimization (Fig. 1a). The paleo-soraphens 1 and 2 exhibit the
structure as defined by the ketoreductase (KR) and dehydratase
(DH) in module 8. Therefore, the hemiacetal moiety is trans-
formed to a trisubstituted double bond. Further in paleo-sora-
phen 2 the double bond between C9 and C10 becomes a
saturated alkyl chain as defined by the enoyl reductase (ER) in
module 5. One post-ketidal modification that could potentially
also provide altered biological activities is the methylation at
the hydroxyl group at C11. In contrast to the methoxy group at
C12, which is incorporated during the polyketidal synthesis,
installation of the methoxy group at this position takes place
by a post-ketidal methylation. This sets the background for the
syntheses of the corresponding paleo-soraphens 3 and 4 that
incorporate the modifications of compounds 1 and 2 but were
exhibiting the hydroxyl group at C11. These compounds would
be structurally even more distant from soraphen A (7) com-
pared to compounds 1 and 2. An additional set of modifi-
cations in this particular area was inversion of configuration at
C11, paleo-soraphen 5 has the opposite configuration at C11
compared to soraphen A (7).
Finally, we completed the synthesis of 17-epi-paleo-sora-
phen F (46), which contains the reduced carbonyl group at C3
but still lacks the elimination step. However, we were not able
to complete the synthesis of paleo-soraphen F (6) without
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inversion of configuration at the ester linkage, despite con-
siderable eﬀort.
Results and discussion
Synthetic considerations and completion of segments
In order to provide rapid access to these modifications we first
worked on an optimized route to the required building blocks
compared to our 1st generation synthesis (Fig. 1b). For this,
the synthesis of a more advanced eastern segment rather than
9 should minimize late-stage manipulations to the paleo-sora-
phens. These strategic considerations lead to evaluate a more
convergent and unified strategy to all soraphens with either
the trisubstituted double bond or the aldol fragment in place.
The essential segments 10 and 12 could be accessed from the
same aldehyde 14 through either a Wittig or an anti-aldol reac-
tion, while the key aldehyde 14 could be conveniently obtained
Fig. 1 (a) Biosynthesis of the soraphen A and paleo-soraphens; (b) retrosynthetic analysis of the paleo-soraphens.
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from (S)-Roche ester (13) by a combination of anti-Marshall
and syn-Evans aldol reaction. The new western segment 11 was
initially prepared by our established route from compounds 15
and 16 in totally 12 steps from commercially available
materials (Scheme 1a). Later, we developed a concise 6-step
route by using an asymmetric alkylation and a Sharpless dihy-
droxylation as the key steps (Scheme 1b). The advantage of
using 11 instead of 8 was the fact that in the endgame of the
synthesis, both the hydroxyl group and the acid required for
the macrolactonization could be liberated in one step.
Thus, under chiral titanium catalysis by a modification of
Wang’s deactivating strategy,4 the first desired stereocenter
was secured and the desired alcohol 20 was obtained in good
yield with high enantioselectivity from 5-hexen-1-ylmagnesium
bromide and benzaldehyde (19). Subsequent hydroxyl protec-
tion and terminal alkene asymmetric dihydroxylation provided
the diol 22 in excellent yield. Finally, three more simple
manipulations (primary hydroxyl group protection with TES,
secondary hydroxyl group methylation and IBX-mediated TES
deprotection/oxidation) completed the western segment 11 in
good overall yield (Scheme 1b).
Meanwhile, for the eastern segments, we changed our pre-
vious synthetic sequence, as shown in Scheme 2. The synthesis
starts from a Marshall reaction with aldehyde 23,5 generated
by an established two-step sequence from Roche ester,6 to
provide the chiral alcohol 24 which was TBS-protected and
then subjected to a hydrozirconation. Treatment of the thus-
generated zirconocene species with iodine produced iodide 26.
The primary TBS group could be selectively removed by treat-
ing the crude iodide 26 with NaIO4 to aﬀord alcohol 27 in
good yields.7
Next, Dess–Martin oxidation of 27 followed by an Evans
aldol reaction provided intermediate 29. With compound 29 in
hand, we were able to obtain lactone 30, which could be used
to independently confirm the established configurations with
the aid of X-ray analysis. In the synthetic direction, the aldol
product 29 was subsequently TBS-protected, the Evans auxili-
ary reductively removed, and the corresponding alcohol 31 was
oxidized by the Dess–Martin reagent to provide aldehyde 14.
From 14, the eastern segment 10, required for the paleo-sora-
phens A–E, was obtained through a Wittig olefination. Mean-
while, an anti-selective Masamune aldol reaction between
aldehyde 14 and chiral ester 33 8 aﬀorded the anti-aldol
product 34, which is required for the synthesis of paleo-sora-
phen F. For further manipulations, 34 could be transferred to
its methyl ester and subsequently protected either as the TBS-
(12a) or MOM-ether (12b).
Completion of paleo-soraphens A–E
Our 1st generation synthesis required a variety of late-stage
manipulations after the NHK coupling (Scheme 3a). With alde-
hyde 11 and vinyl iodide 10 in hand, we then commenced on
the 2nd generation synthesis. The NHK coupling between 11
and 10 provided the desired product albeit with moderate
selectivity. Fortunately, the diastereoisomers 36 and 37 could
be easily separated from each other. Continuing with com-
pound 36, hydroxyl acid 38 was obtained through a two-step
sequence involving methylation and basic saponification.
Macrolactonization under Shiina conditions9 and the removal
of the TBS groups completed a 23-step synthesis of paleo-sora-
phen A (1) compared to 32 steps for our 1st generation route.
For the synthesis of paleo-soraphen C (3), the C-11 hydroxyl
group in compound 36 was protected as the TBS ether and the
subsequent three same transformations completed the syn-
thesis of this paleo-soraphen. For the completion of the paleo-
soraphens B (2) and D (4), the selective reduction of the C9,
C10-double bond was required and proved to be non-trivial.
This reduction was finally achieved with Adam’s catalyst and
provided the desired product 39 in 72% yield along with
ketone 40 in 21% yield. Ketone 40 could be converted to 39 by
reduction with Zn(BH4)2.
10 Finally, the syntheses of the paleo-
soraphens B and D were completed in four further steps from
39 respectively. While continuing with isomer 37, paleo-sora-
phen E (5) could be easily completed by the established
sequence of methylation, saponification, macrocyclization and
final deprotection.
Towards paleo-soraphen F (6) and completion of 17-epi-paleo-
soraphen F (46)
For the synthesis of paleo-soraphen F, we first started from
aldehyde 11 and vinyl iodide 12a. Following our established
3-step sequence,3 the NHK coupling product 41 was obtained
Scheme 1 First- and second-generation approaches to the shared
western segment 11. Reagents and conditions: (a) 1.5 mol% Grubbs 2nd
generation catalyst, CH2Cl2, 65%; (b) PtO2, H2 (1 atm.), EtOAc, 81%; (c)
DMAP, Ac2O, Et3N, CH2Cl2, 96%; (d) CSA, MeOH; (e) IBX, DMSO, 85%, 2
steps; (f ) 5-hexen-1-ylmagnesium bromide, Ti(OiPr)4, (S)-BINOL,
BDMAEE, 54%, 88% ee; (g) DMAP, Ac2O, Et3N, CH2Cl2, 100%; (h) AD-
mix-α, tBuOH–H2O, 91%; (i) TESCl, imidazole, DMAP, DMF; ( j) Ag2O,
MeI, Et2O; (k) IBX, DMSO, 74%, 3 steps. DMAP = 4-dimethyl-
aminopyridine; CSA = camphorsulfonic acid; IBX = 2-iodoxybenzoic
acid; (S)-BINOL = (S)-(−)-1,1’-bis(2-naphthol); BDMAEE = bis(2-di-
methylaminoethyl)ether; TESCl = chlorotriethylsilane.
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as a single diastereoisomer. Subsequent methylation provided
42 and basic saponification liberated hydroxyl acid 43 albeit
with concomitant loss of the C3 protecting group. Unfortu-
nately, macrolactonizations by acid activation protocols
(Shiina, Yamaguchi, Mukaiyama methods, etc.) were un-
successful to get 44. Thus, we decided to enter from the steri-
cally hindered carboxylic acid moiety, and to our delight, the
expected macrolactone 45 was obtained in good yield under
Mitsunobu reaction conditions. Subsequent removal of both
TBS groups aﬀorded a new soraphen (17-epi-paleo-soraphen E,
46) (Scheme 4).
Encouraged by these results, we employed 17-epi-11 in the
NHK coupling and obtained compound 47 by the same strat-
egy. To our surprise, its Mitsunobu reaction produced only a
trace of the desired product 48 but the eliminated product 49
always dominated significantly under various conditions
[Scheme 5, eqn (1)]. Obviously, the inversion of configuration
at C-17 caused steric eﬀects resulting in very slow macrocycli-
zation compared to elimination. Thus, we used the MOM-
protected vinyl iodide 12b, and repeated this sequence again.
Unfortunately, this time basic hydrolysis only provided the
undesired elimination product 17-epi-38 [Scheme 5, eqn (2)].
Finally, a strategy based on a ring-closing metathesis reac-
tion (RCM) was also conceived and evaluated (Scheme 6).
From the known compound 51,11 aldehyde 52 was con-
veniently obtained and following our established 3-step route,
coupling product 53 was obtained in good overall yield. Sub-
sequent methylation and ester saponification gave us the
desired corresponding acid. Then, an intermolecular esterifica-
tion under Mitsunobu conditions cleanly provided the meta-
thesis precursor 54 in good yield, which to some extent was
evidence that steric hindrance was the cause of the failure of
Scheme 2 Syntheses of the eastern segments 10 and 12. Reagents and conditions: (a) (R)-but-3-yn-2-yl-methanesulfonate, Pd(OAc)2, PPh3, Et2Zn,
THF, 80%; (b) 2,6-lutidine, TBSOTf, THF, −78 °C, 94%; (c) Cp2ZrCl2, LiHBEt3, THF, then I2; (d) NaIO4, THF/H2O, 78%, 2 steps; (e) DMP, NaHCO3,
CH2Cl2, 92%; (f ) (R)-4-benzyl-3-(2-methoxyacetyl)oxazolidin-2-one, Bu2BOTf, Et3N, CH2Cl2, 91%; (g) 70% HF in pyridine, THF; (h) 2,6-lutidine,
TBSOTf, CH2Cl2, 68%, 2 steps; (i) 2,6-lutidine, TBSOTf, CH2Cl2; ( j) LiBH4, THF, 87%, 2 steps; (k) DMP, NaHCO3, CH2Cl2, 95%; (l) 32, CH2Cl2, 95%, 2
steps from 31; (m) 33, Cy2BOTf, Et3N, CH2Cl2, 88%; (n) NaOMe, MeOH/THF, 88%; (o) 2,6-lutidine, TBSOTf, CH2Cl2, 91%; (p) MOMCl, DIPEA, CH2Cl2,
90%. TBSOTf = tert-butyldimethylsilyl triﬂuoromethanesulfonate; DMP = Dess–Martin periodinane; MOMCl = chloromethyl methyl ether.
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the macrolactonization of 47. Nevertheless, the key RCM to
provide compound 55 failed under various conditions utilizing
ruthenium catalysts.
Biological studies of the paleo-soraphens
To compare biological activities of the paleo-soraphens, we
characterized them via impedance profiling. Time-dependent
cellular response profiles (TCRP) were recorded by using the
xCELLigence system (ACEA Biosciences, RTCA SP Instrument).
Abassi et al. showed that compounds with a similar mode of
action often induce similar time-dependent response pro-
files.12 The method is therefore suited to get first hints of the
mechanisms of biological activities of substances. Soraphen A
is known to inhibit the eukaryotic acetyl CoA carboxylase
(ACC), which plays an essential role in fatty acid synthesis and
degradation. To monitor this eﬀect in cell culture we used
L-929 mouse fibroblasts that were grown in Dulbecco’s modi-
fied Eagle’s medium (DMEM) with 10% FBS for 24 h. Experi-
ments on the kinetics of the soraphen A action showed that
the inhibitory eﬀect in cell cultures is delayed, and this delay
is dependent on the serum concentration. Despite the fact that
soraphen A blocks fatty acid synthesis, the cells obviously feed
Scheme 3 Synthesis of paleo-soraphens A–E. Reagents and conditions: (a) NiCl2, CrCl2, DMSO; (b) Ag2O, MeI, 4 Å MS, Et2O; (c) LiOH, THF/MeOH/
H2O; (d) MNBA, DMAP, 4 Å MS, toluene; (e) 70% HF in pyridine, THF; (f ) 2,6-lutidine, TBSOTf, CH2Cl2; (g) PtO2, H2 (1 atm.), EtOAc; (h) Zn(BH4)2, Et2O.
MNBA = 2-methyl-6-nitrobenzoic anhydride.
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on the fatty acids provided by the serum for a certain time. To
monitor the eﬀect of the fatty acid synthesis inhibitors the
medium was therefore changed to DMEM with 2% FBS to
reduce the fatty acids supply by the culture medium before
compound addition. As reference compounds we included sor-
aphen A, TOFA – also a known inhibitor of fatty acid synthesis
that blocks the synthesis of malonyl-CoA by ACC13 – and ceru-
lenin, a natural inhibitor of fatty acid synthase (FAS).14 The
impedance measurements were carried out as described
before3,15 with slight alterations. The L-929 cells were incu-
bated with paleo-soraphens A, C, D, E and 17-epi-paleo-sora-
phen F (25 µg mL−1), soraphen A (25 µg mL−1), TOFA (10 µg
mL−1) and cerulenin (2.7 µg mL−1) in wells of a 96-well E-plate
which had gold electrodes integrated in the bottom of the
wells. Impedance across the electrodes was measured in tripli-
cates for each compound over 5 days, and cell indices were
recorded by the RTCA Software (Version 1.2). Further data pro-
cessing was carried out using the statistical programming
language R.16 After importing the raw data, the TCRPs were
normalized by dividing each measured cell index after com-
pound addition by the last cell index measured before com-
pound addition (reference time point). For subsequent
analysis, only the measurements starting at the reference time
point (with normalized cell index = 1) and later were con-
Scheme 4 Towards paleo-soraphen F and completion of 17-epi-paleo-soraphen F (46) by an intramolecular Mitsunobu approach. Reagents and
conditions: (a) NiCl2, CrCl2, DMSO; (b) DMP, NaHCO3, CH2Cl2; (c) Zn(BH4)2, Et2O, 58%, 3 steps; (d) Ag2O, MeI, 4 Å MS, Et2O, 96%; (e) LiOH, THF/
MeOH/H2O, 79%; (f ) PBu3, DIAD, toluene/THF, 76%; (g) 70% HF in pyridine, THF, 67%. DIAD = diisopropyl azodicarboxylate.
Scheme 5 Towards paleo-soraphen F by the intramolecular-Mitsunobu approach. Reagents and conditions: (a) PBu3, DIAD, toluene/THF; (b) LiOH,
THF/MeOH/H2O, 49%.
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sidered. From the triplicate measurements median TCRPs
were calculated. The median TCRPs were then normalized
using median cell indices from the appropriate DMSO control
(cells incubated with the same amount of DMSO used for com-
pound treatment). To achieve dimension reduction we used
cubic smoothing splines to fit the median TCRPs and used the
basis spline coeﬃcients as descriptors to construct a distance
matrix using the Euclidean distance function. We carried out
hierarchical cluster analysis and constructed a heatmap dis-
playing the Z-transformed values of the 22 descriptors of each
TCRP (Fig. 2). The hierarchical cluster analysis shows that sora-
phen A and paleo-soraphen A are found within one cluster
with TOFA, in agreement with previous results.3 The pheno-
type induced by paleo-soraphen A in the xCELLigence assay is
thus most closely related to the one induced by soraphen
A. Paleo-soraphens C and D are found within one cluster that
is more distant to soraphen A. Their closely related phenotype
in this assay could be explained by the absence of a methyl-
group (hydroxy instead of methoxy) at C11. This feature is
unique in paleo-soraphens C and D. Since these methylations
are done as post-ketidal transformations the larger distance in
the dendrogram is consistent with an optimization of the bio-
logical activity starting from the unmodified polyketide to sora-
phen A. Paleo-soraphen E on the other hand, that exhibits only
the opposite configuration at C11 is much more closely related
to paleo-soraphen A. Although paleo-soraphen E is found
within one compact cluster together with the FAS inhibitor cer-
ulenin, its profile shows also similarities with paleo-soraphen
A, especially the first three descriptors corresponding to the
early events after compound addition are quite similar. 17-epi-
Paleo-soraphen F, which is biosynthetically between soraphen
A and paleo-soraphen A takes a more distant position in the
hierarchical cluster analysis.
Conclusions
In conclusion, we were able to provide additional paleo-sora-
phens. The design of these additional variations of the sora-
phen family was based on hypothetical biosynthetic precursors
that could provide evidence for the evolutionary optimization
of these compounds in retrospect. The paleo-soraphens C and
D are lacking the methylation at C11 which was shown to be a
post-ketidal transformation. The hierarchical cluster analysis
shows that these soraphens are more distant from soraphen A
than the paleo-soraphens A and B which from an evolutionary
point of view is consistent with an optimization of its biologi-
cal activity. The hierarchical positioning of 17-epi-paleo-
soraphen F on the other hand, is not paralleled by its syn-
thetical positioning between soraphen A and paleo-soraphen
A. However, it has to be mentioned that the results from
17-epi-paleo-soraphen F are not clear-cut since the configuration
at C17 was changed as well. Changing the configuration at C11
also seems to have influenced the activity.
Taking all these results together, we have now gathered
more evidence that at least in the case of the soraphens
an optimization and maybe even introduction of biological
Scheme 6 Towards paleo-soraphen F by RCM-approach. Reagents and conditions: (a) NaBH4, THF/H2O, 83%; (b) SO3
•pyridine, Et3N, DMSO,
CH2Cl2, 85%; (c) NiCl2, CrCl2, DMSO; (d) DMP, NaHCO3, CH2Cl2; (e) Zn(BH4)2, Et2O, 67%, 3 steps; (f ) Ag2O, MeI, 4 Å MS, Et2O, 97%; (g) LiOH, THF/
MeOH/H2O, 81%; (h) (R)-1-phenylbut-3-en-1-ol, PBu3, DIAD, toluene/THF, 80%.
Fig. 2 Hierarchical cluster analysis of impedance kinetics. The heatmap
displays Z-transformed descriptors derived from basis spline
coeﬃcients.
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activity has emerged from a non-related activity through alter-
ing the polyketide assembly line and post-ketidal modification.
Tracing back the origin of biological activities in natural pro-
ducts might help us to understand the origin of natural pro-
ducts and their biological activity as well as provide hints for
new targets in the realm of medicinal chemistry.
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